Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2023 | Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062 | JAPANESE JOURNAL OF CLINICAL ONCOLOGY |